Molecular probes directed to the delta opioid receptor and associated methods of use as non-invasive diagnostics for lung cancer are presented. The molecular probes generally consist of a ligand (Dmt-Tic) that is conjugated to a detection moiety such as a fluorescent dye or a radionuclide by a linker molecule. Once the probe is administered, it may be detected by a molecular imaging device to locate tumors for treatment or removal. Also presented are novel markers for lung cancer including, but not limited to, CA9, CA12, CTAG2, CXorf61, DSG3, FAT2, KISS1R, GPR87, LYPD3, OPRD1, SLC7A11 and TMPRSS4. Probes may be developed that can target these cell surface markers.
针对δ阿片受体的分子探针以及作为非侵入性肺癌诊断方法的相关用途被提出。这些分子探针通常由一个
配体(Dmt-Tic)与一个检测基团(如荧光
染料或放射性核素)通过连接分子结合在一起。一旦给予这种探针,它可以被分子成像设备检测,以定位肿瘤进行治疗或切除。此外,还提出了肺癌的新标记物,包括但不限于CA9、C
A12、CTAG2、CXorf61、DSG3、FAT2、KISS1R、GPR87、LYPD3、OPRD1、SLC7A11和
TMPRSS4。可以开发出能够靶向这些细胞表面标记物的探针。